Priority Date: 08.11.10 (US 20100411015P)

Subcutaneously administered ANTI-IL-6 receptor antibody

  • Application ID: EP13198771
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). F. Hoffmann-La Roche AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.11.2010 - Priority Date (US 20100411015P)
  • 08.10.2014 - Publication A2 (EP2787007)
  • 11.03.2015 - Publication A3 (EP2787007)

IPC Classification